Sotatercept Reverses SIN3a Deficiency-Driven PAH by Reprogramming BMPR2/TGF-β-HIF-1α Signaling Pathways
Katherine Jankowski, Anurupa Ghosh, Marîa Teresa Ochoa, Z. Shihong, Gregory David, Irene C. Turnbull, Malik Bisserier, Lahouaria Hadri
This study shows that Sotatercept reverses SIN3a deficiency-driven pulmonary arterial hypertension by reprogramming BMPR2/TGF-β-HIF-1α signaling pathways.
bioRxiv · Feb 3, 2026 · PreprintMolecular Biology